TNFRSF8, TNF receptor superfamily member 8, 943

N. diseases: 301; N. variants: 1
Disease: Nodular Lymphocyte Predominant Hodgkin Lymphoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1334968
Disease: Nodular Lymphocyte Predominant Hodgkin Lymphoma
Nodular Lymphocyte Predominant Hodgkin Lymphoma 		0.320 Biomarker disease BEFREE Two cases were "monomorphic" with immunoblastic histology, and 5 cases were "polymorphic" with histologic aspects reminiscent of nodular lymphocyte-predominant Hodgkin lymphoma (2 cases) and of CD30+ classical Hodgkin lymphoma (3 cases). 25704629 2015
CUI: C1334968
Disease: Nodular Lymphocyte Predominant Hodgkin Lymphoma
Nodular Lymphocyte Predominant Hodgkin Lymphoma 		0.320 AlteredExpression disease BEFREE Distinguishing EBV(+) NLPHL from CHL can be challenging, as EBV(+) NLPHL can have partial expression of CD30 and weak PAX5 staining as well as pleomorphic-appearing LP cells. 24525501 2014
CUI: C1334968
Disease: Nodular Lymphocyte Predominant Hodgkin Lymphoma
Nodular Lymphocyte Predominant Hodgkin Lymphoma 		0.320 Biomarker disease CTD_human Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. 16879607 2006
CUI: C1334968
Disease: Nodular Lymphocyte Predominant Hodgkin Lymphoma
Nodular Lymphocyte Predominant Hodgkin Lymphoma 		0.320 Biomarker disease CTD_human Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma. 12453859 2002